VANCOUVER,
June 23, 2017
/CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus MD"
or the "Company") (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased
to announce its inclusion in the Horizon Medical Marijuana Life
Sciences ETF (TSX:HMMJ) ("HMMJ ETF"), which is trading, and is the
first ETF to offer direct exposure to North American-listed stocks
that operate in the legal medical cannabis
industry.
Horizon Medical Marijuana Life Sciences ETF is the first
exchange-traded fund that offers investors direct exposure to North
American-listed stocks that are involved with biopharmaceuticals,
medical manufacturing, distribution, bio-products, and
other businesses ancillary to the marijuana industry.
Invictus MD joins the 19 other constituents. Only stocks that meet
minimum asset and liquidity thresholds are qualified for
inclusion in the index, and no single stock may exceed 10% of the
weight of the Index when rebalanced.
"Invictus MD's inclusion to Horizon's Marijuana Life
Sciences Index ETF represents an important achievement for our
company and recognizes the enormous efforts and successes of our
team," said Dan Kriznic, Executive Chairman. "Inclusion in the
ETF will help broaden participation in Invictus MD's shares, and
improve trading liquidity for our shareholders."
About Invictus MD Strategies Corp.
Invictus MD Strategies Corp. is focused on two main
verticals within the burgeoning Canadian cannabis sector: Licensed
Producers under the ACMPR, including its wholly owned subsidiary
Acreage Pharms Ltd., as well as its investment in the fully
licensed facility AB Laboratories Inc.; and Fertilizer and
Nutrients through Future Harvest Development
Ltd.
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
For more information, please visit
www.invictus-md.com.
On Behalf of the Board,
Dan
Kriznic
Executive Chairman
Larry
Heinzlmeir
Vice President, Marketing &
Communications
604-537-8676
SOURCE Invictus MD Strategies